Elite Pharmaceuticals/ US28659T2006 /
2024-04-19 4:21:54 PM | Chg. -0.0008 | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
0.1327USD | -0.60% | 82,610 Turnover: 10,948.6250 |
-Bid Size: - | -Ask Size: - | 0.1340 | 0.1320 |
GlobeNewswire
2019-03-13
SunGen Pharma and Athenex Pharmaceutical Division Announce Busulfan Injection Product Launch
GlobeNewswire
2019-03-11
Elite Pharmaceuticals Enters into Strategic Marketing Alliance with Lannett For Generic Adderall®
GlobeNewswire
2019-03-11
Elite Pharmaceuticals Enters into Strategic Marketing Alliance with Lannett For Generic Adderall®
GlobeNewswire
2019-02-12
Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2019 Ende...
GlobeNewswire
2019-02-07
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Qu...
GlobeNewswire
2018-12-10
Elite Pharmaceuticals and SunGen Pharma Receive FDA Approval for Generic Adderall®
GlobeNewswire
2018-08-14
Elite Pharmaceuticals Reports Positive Topline Results from a Pivotal Bioequivalence Study
GlobeNewswire
2018-08-09
Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2019 Ende...
GlobeNewswire
2018-08-07
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Qu...
GlobeNewswire
2018-08-07
Elite Pharmaceuticals Appoints Aqeel A. Fatmi, Ph.D. to Its Board of Directors
GlobeNewswire
2018-08-06
Elite Pharmaceuticals Receives FDA Approval for Generic Methadone Hydrochloride Tablets
GlobeNewswire
2018-06-14
Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2018 and P...
GlobeNewswire
2018-06-14
Elite Pharmaceuticals, Inc. Announces Passing of Board Member Eugene Pfeifer
GlobeNewswire
2018-06-11
Elite Pharmaceuticals, Inc. to Host Conference Call to Discuss Year-end Financial Results on June 15...
GlobeNewswire
2018-05-30
Elite Pharmaceuticals and SunGen Pharma File ANDA for Extended-Release CNS Stimulant